Technology transfer is the process of moving knowledge, inventions, or technology developed in one place and applying it somewhere else. Most often, this means taking a discovery made in a university lab or government research institution and turning it into a product, service, or process that reaches the real world. The concept applies broadly, from a professor’s biomedical breakthrough becoming a new drug to an engineering prototype scaling up into factory production.
How Tech Transfer Works
The process follows a general path from discovery to commercialization, though the details vary by institution and industry. MIT’s Technology Licensing Office breaks it into three core stages: disclosure, patenting, and commercialization.
It starts when a researcher creates something new and reports it to their institution’s technology transfer office (TTO). This is called an invention disclosure. The TTO evaluates whether the invention has commercial potential and, if so, files for patent protection. From there, the office looks for companies willing to license the technology, negotiate terms, and structure a deal that lets the company develop and sell the product while the university and inventor earn revenue. That revenue cycles back into funding more research.
In industry settings, particularly in biotech and manufacturing, the process looks slightly different. When a company needs to move a product from a research lab to a production facility, tech transfer typically involves four stages: knowledge transfer (sharing all the data and documentation), preparation (getting the receiving site ready with equipment and timelines), execution (starting production with guidance from the original team), and close-out. This is common when a pharmaceutical company scales up a drug from small lab batches to commercial manufacturing.
What Technology Transfer Offices Do
Universities and research institutions house dedicated offices that manage this entire pipeline. These offices handle invention disclosures, file patent applications, market technologies to potential licensees, and negotiate licensing agreements. Their performance is typically measured by the number of patents filed, licenses executed, and royalties generated.
Generating royalties and fees is consistently ranked as the top priority for these offices, but it’s not the only one. TTOs also aim to spark sponsored research partnerships with companies and get inventions into the market regardless of monetary return. A technology that improves public health or addresses poverty, for example, may be worth transferring even if the licensing revenue is modest.
Types of Licensing Agreements
Once a technology is ready for commercialization, the institution and the licensee agree on terms through a license. The structure of that license determines who can use the technology and how.
- Exclusive license: One company gets sole rights to commercialize the invention. This is common when significant investment is needed to bring a product to market, since companies want assurance they won’t face direct competition using the same technology.
- Non-exclusive license: Multiple companies can license and use the same technology simultaneously. This works well for broadly useful tools or methods.
- Commercial evaluation license: A company gets temporary, non-exclusive rights to test a technology and assess whether it’s worth pursuing commercially.
- Internal use license: A company can make and use the invention for its own operations but not sell it as a product.
The Law That Made It Possible
Before 1980, inventions created with federal research funding generally belonged to the government, and very few ever made it to market. The Bayh-Dole Act changed that by allowing universities and small businesses to own and patent inventions developed with government money. The impact was enormous. Patents filed under Bayh-Dole rose from 1,635 in 1981 to 7,911 in 2020, and nine of the top 15 recipients of these patents are academic institutions. The law is widely credited with building the foundation for modern university tech transfer in the United States.
Real-World Examples
Some of the most recognizable products and companies trace back to university tech transfer. Google famously originated from a Stanford research project. Gatorade was developed at the University of Florida. But tech transfer doesn’t always produce household names. At Colorado State University, faculty-developed wheat varieties now account for 85% of wheat grown in the state and bring in nearly $2 million annually in royalties. Two CSU engineering students and their professors co-founded Envirofit International in 2003, a company that has since sold more than 2.5 million clean cookstoves benefiting an estimated 12 million people in developing nations. Another CSU researcher founded Prieto Batteries to commercialize a novel three-dimensional lithium-ion battery. And a first-of-its-kind heart valve replacement for a chronic cardiac condition recently received FDA approval based on university research.
These examples show the range of what tech transfer produces: agricultural improvements, consumer products, medical devices, clean energy solutions, and entirely new companies.
The “Valley of Death” Problem
The biggest challenge in tech transfer is crossing what’s known as the “valley of death,” the gap between a working lab prototype and a viable commercial product. Many promising inventions never make it across. The reasons are both financial and technical. Developing a product from a proof-of-concept to something manufacturable and marketable requires significant capital, complex technical support, and a long accumulation period. The knowledge needed spans multiple domains (science, engineering, manufacturing, regulation, market strategy), and combining those different kinds of expertise is inherently difficult.
Companies and universities struggle with this gap because the technology works in controlled conditions but hasn’t been tested against real-world constraints like cost, scale, supply chains, and customer needs. Bridging that divide requires not just money but the ability to connect what’s technically possible with what the market actually wants.
Patents vs. Trade Secrets
Organizations face a strategic choice about how to protect their technology during transfer. Patents offer strong legal protection but require publicly disclosing how the invention works, which can limit how much knowledge actually flows between parties. Research published in Economics Letters found that stronger patent protection stimulates foreign investment but can actually reduce overall technology transfer, because patents directly limit a domestic company’s ability to learn from and build on the technology.
Trade secret protection takes the opposite approach, keeping proprietary know-how confidential rather than disclosing it in a patent filing. Interestingly, the same research found that moderate trade secret protection can encourage both investment and knowledge sharing. It gives the technology holder enough confidence to allow skilled workers to move between organizations, carrying tacit knowledge (the hands-on expertise that can’t easily be written down) with them. Technology transfer tends to be maximized at an intermediate level of protection: strong enough to make companies comfortable sharing, but not so restrictive that knowledge gets locked away.
In practice, most organizations use a combination. Patentable inventions get filed, while production know-how, specialized techniques, and process details are protected as trade secrets and shared selectively through licensing agreements and partnerships.